Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Lucientes

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nephron|May 6, 2020
Update on C3 Glomerulopathy: A Complement-Mediated DiseaseFernando Caravaca-Fontán, Laura Lucientes, Teresa Cavero, et al.
Immunological Reviews|November 16, 2022
The Factor H protein family: The switchers of the complement alternative pathwayLaura Lucientes-Continente, Bárbara Márquez-Tirado, Elena Goicoechea de Jorge
Clinical Kidney Journal|February 10, 2021
Urinary soluble CD163 as a biomarker of disease activity and relapse in antineutrophil cytoplasm antibody-associated glomerulonephritisJavier Villacorta, Laura Lucientes, Elena Goicoechea, et al.
Kidney International|November 3, 2023
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitisLaura Lucientes-Continente, Gema Fernández-Juárez, Bárbara Márquez-Tirado, et al.
Journal of Innate Immunity|March 26, 2025
Development and Characterization of Novel ELISAs for the Specific Quantification of the Factor H-Related Proteins 2, 3, 4, and 5Mara van Rossum, Bert R J Veuskens, Mieke C Brouwer, et al.
Journal of the American Society of Nephrology : JASN|May 11, 2022
Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 GlomerulopathyBárbara Márquez-Tirado, Josué Gutiérrez-Tenorio, Agustín Tortajada, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 22, 2021
C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapiesFernando Caravaca-Fontán, Laura Lucientes, Núria Serra, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2020
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the DiseaseFernando Caravaca-Fontán, Montserrat M Díaz-Encarnación, Laura Lucientes, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nephron|May 6, 2020
Update on C3 Glomerulopathy: A Complement-Mediated DiseaseFernando Caravaca-Fontán, Laura Lucientes, Teresa Cavero, et al.
Immunological Reviews|November 16, 2022
The Factor H protein family: The switchers of the complement alternative pathwayLaura Lucientes-Continente, Bárbara Márquez-Tirado, Elena Goicoechea de Jorge
Clinical Kidney Journal|February 10, 2021
Urinary soluble CD163 as a biomarker of disease activity and relapse in antineutrophil cytoplasm antibody-associated glomerulonephritisJavier Villacorta, Laura Lucientes, Elena Goicoechea, et al.
Kidney International|November 3, 2023
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitisLaura Lucientes-Continente, Gema Fernández-Juárez, Bárbara Márquez-Tirado, et al.
Journal of Innate Immunity|March 26, 2025
Development and Characterization of Novel ELISAs for the Specific Quantification of the Factor H-Related Proteins 2, 3, 4, and 5Mara van Rossum, Bert R J Veuskens, Mieke C Brouwer, et al.
Journal of the American Society of Nephrology : JASN|May 11, 2022
Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 GlomerulopathyBárbara Márquez-Tirado, Josué Gutiérrez-Tenorio, Agustín Tortajada, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 22, 2021
C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapiesFernando Caravaca-Fontán, Laura Lucientes, Núria Serra, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2020
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the DiseaseFernando Caravaca-Fontán, Montserrat M Díaz-Encarnación, Laura Lucientes, et al.
Pageof 1